Kreps Edward Jay 4

4 · Confluent, Inc. · Filed Dec 16, 2025

Insider Transaction Report

Form 4

Period: 2025-12-12

Confluent, Inc.CFLT

Kreps Edward Jay

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Conversion
Class A Common Stock
2025-12-12+506,000→ 845,367 total
Sale
Class A Common Stock
2025-12-12$30.04/sh−506,000$15,200,240→ 339,367 total
Conversion
Class A Common Stock
2025-12-15+232,500→ 571,867 total
Sale
Class A Common Stock
2025-12-15$30.10/sh−232,500$6,998,250→ 339,367 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−506,000→ 1,219,153 total
Exercise: $2.24Exp: 2028-10-21→ Class B Common Stock (506,000 underlying)
Exercise/Conversion
Class B Common Stock
2025-12-12+506,000→ 14,988,500 total
→ Class A Common Stock (506,000 underlying)
Conversion
Class B Common Stock
2025-12-12−506,000→ 14,482,500 total
→ Class A Common Stock (506,000 underlying)
Conversion
Class B Common Stock
2025-12-15−232,500→ 14,250,000 total
→ Class A Common Stock (232,500 underlying)

Holdings

Class B Common Stock
(indirect: See footnote)
→ Class A Common Stock (149,984 underlying)
149,984
Class B Common Stock
(indirect: See footnote)
→ Class A Common Stock (1,000,000 underlying)
1,000,000

Footnotes (8)

[F1]Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
[F2]The shares were sold at prices ranging from $30.02 to $30.10. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]Shares sold pursuant to a 10b5-1 trading plan adopted August 15, 2024.
[F4]The shares were sold at prices ranging from $30.05 to $30.14. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]Fully vested.
[F6]The shares are held by The Edward J. Kreps and Jamaica H. Kreps 2018 Revocable Trust.
[F7]The shares are held by the GST Exempt Trust under The Kreps Family 2019 Irrevocable Trust under agreement dated 9/26/2019.
[F8]The shares are held by the GST Exempt Trust under The Kreps Family 2019 Irrevocable Trust under agreement dated 9/26/2019.

Documents

1 file

4
form4-12162025_041207.xmlPrimary